| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |